Néevo® - Néevo®DHA

Néevo®, a prescription prenatal vitamin, is indicated for the distinct nutritional requirements of older OB patients, high-risk pregnancies and OB patients with the MTHFR folate polymorphism. Néevo® includes all of the traditionally prescribed prenatal vitamins as recommended by ACOG. Néevo®DHA contains 250mg of the essential fatty acid, DHA - taken from a plant source.

The ingredient that makes Néevo® and Néevo® unique is the inclusion of L-methylfolate: nature's active form of folate as found in leafy green foods. L-methylfolate is superior to synthetic folic acid in many ways*:

  • L-methylfolate increases RBC folate concentrations more effectively than folic acid.
  • L-methylfolate reduces homocysteine more effectively than folic acid.
  • L-methylfolate is 7 times more bioavailable than folic acid.
  • L-methylfolate bypasses the C677T MTHFR polymorphism. Folic acid does not.

Introducing Néevo®DHA, the very best folate will be married to the very best DHA omega-3. Please see package insert for full prescribing details.

* All L-methylfolate references are found on www.neevoprenatal.com or www.neevodha.com.

Néevo® is a prescription prenatal multivitamin/multimineral caplet for the dietary management of women under a doctor's care who face high to intermediate risk pregnancies, older OB patients and patients unable to fully metabolize folic acid.

Néevo®DHA is a prescription prenatal multivitamin/multimineral capsule with DHA for the dietary management of preconception and pregnant women who require increased vitamin, mineral and DHA concentrations throughout pregnancy and the post lactating period.

More from our Product Family
  • Metanx®: The active, natural occurring B-vitamins in Metanx® are directly associated with metabolizing homocysteine, a risk factor for vascular disease, and improving the overall health of the blood vessels.
  • Diatx®Zn is a medical food indicated for the distinct nutritional requirements of patients under a physician's treatment for hyperhomocysteinemia with particular emphasis for those individuals diagnosed with chronic kidney disease (CKD), end stage renal disease (ESRD) or dialysis.